Lilly’s Retatrutide Delivers Greater Weight Loss Than Ozempic In Trial
Eli Lilly and Company has reported positive topline results from a Phase 3 clinical trial in which its investigational drug retatrutide delivered greater reductions in blood sugar…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 29 10:35 ETSource: BW Healthcare World
From the source
Read at bwhealthcareworld.comLilly’s Retatrutide Delivers Greater Weight Loss Than Ozempic In Trial
Eli Lilly and Company has reported positive topline results from a Phase 3 clinical trial in which its investigational drug retatrutide delivered greater reductions in blood sugar levels and more than double the weight loss achieved with Ozempic 2 mg in adults with Type 2 diabetes.
